December 24, 2014 article Open access A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response Clinical Cancer Research DOI: 10.1158/1078-0432.ccr-14-2708 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 8 stored of 807 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system 2024 Frontiers in Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access 6 citations Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases 2024 BMJ Oncology article Medicine Sarcoma Diagnosis and Treatment Open access 1 citations TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer 2024 Cancer Discovery article Medicine CAR-T cell therapy research Open access cited by 2 patents 14 citations Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies 2024 American Society of Clinical Oncology Educational Book article Medicine CAR-T cell therapy research 30 citations Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma 2024 The Cancer Journal article Medicine Cancer Immunotherapy and Biomarkers 2 citations TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer in near-clinical models 2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine CAR-T cell therapy research Open access 1 citations New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC – Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas 2022 European Journal of Cancer article Medicine Sarcoma Diagnosis and Treatment Open access cited by 1 patent 14 citations A matter of life or death: targeting MCL-1 in multiple myeloma 2021 dissertation Biochemistry, Genetics and Molecular Biology Cell death mechanisms and regulation Open access 0 citations 8 results Cited by imported patents 1 (EPO, DOI in their cited literature) T CELL RECEPTORS DIRECTED AGAINST CANCER-ASSOCIATED ANTIGENS AND USES THEREOF 2024 WO2024101994A1 +1 publications Chemistry & metallurgy 2 offices References 0